2019 – Page 3 – Policy & Medicine

Accountable Care Organizations (ACO’s) Contributing to Clinician Consolidations into Large Practices

FDA Publishes Postmarket Surveillance Best Practices

CMS Finalized Rule Banning Troubled Clinicians from Medicare

Johnson & Johnson Still Dealing with Risperdal Lawsuits

DEA Amends Regulations Applicable to Registrants Ordering Certain Controlled Substances

POD Kickbacks Land Entire Medical System in Hot Water

Health Coverage Transparency Proposed Rule Would Require Insurers to Disclose Out-of-Pocket Costs

Trump Administration Releases Hospital Price Transparency Final Rule

FDA Issues Draft Guidance on Patient Engagement in Medical Device Trials

Analysis of Hospital Chargemasters Shows Hospitals Have Room for Improvement in Usability